C-F. Chiu

Concordance of Post-consolidation Minimal Residual Disease Rates by Multiparametric Flow Cytometry and Next-generation Sequencing in CASSIOPEIA

P. Sonneveld, M. Béné, P. Moreau, 2019, Clinical Lymphoma Myeloma and Leukemia.

Cisplatin as an active treatment in zoledronate-refractory hypercalcemia.

P-H Lin, C-F. Chiu, Y. Lu, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

1209P A phase II study of regorafenib in combination with nivolumab in patients with recurrent or metastatic solid tumors: Results of the ESCC cohort

B. Keam, I. Waxman, S. Pernot, 2022, Annals of Oncology.

A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer.

K. Rau, Chih-Hung Hsu, Chung-Pin Li, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.